Baricitinib or Tocilizumab? Treatment of Patients Hospitalized With Severe COVID-19. | Crit Care Med;51(3): 413-415, 2023 03 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Baricitinib or Tocilizumab? Treatment of Patients Hospitalized With Severe COVID-19.

Cawcutt, Kelly A; Kalil, Andre C.

Cawcutt KA; Both authors: Department of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE.

Crit Care Med ; 51(3): 413-415, 2023 03 01.

Article in English | MEDLINE | ID: covidwho-2254048

Subject(s)

COVID-19; Humans; COVID-19 Drug Treatment; Antibodies, Monoclonal, Humanized; Treatment Outcome

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Crit Care Med Year: 2023 Document Type: Article Affiliation country: CCM.0000000000005757

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Crit Care Med Year: 2023 Document Type: Article Affiliation country: CCM.0000000000005757